Spirometer Market Report Scope & Overview:

The Spirometer Market size was valued at USD 1346.16 million in 2025 and is expected to reach USD 3720.24 million by 2035, growing at a CAGR of 10.70% over the forecast period 2026-2035. 

The spirometer market is increasing with the growing frequent respiratory illness faced by the individuals along with the rise of manufacturing due to technological advancements and the increasing emphasis on healthcare prevention itself. Chronic conditions like asthma and COPD, affecting more than 300 million and 380 million people globally respectively, ramp up the need for such treatments. Portable spirometers are leading the market with a deployment growth of more than 30% over the past five years, driven by digital platforms along with mobile integration and real time monitoring. AI SD validity on diagnosis: 15–20% more specific Demand for home-based spirometry also increased by nearly 40% due to the COVID-19 pandemic. Test's reliability is assured by regulatory guidelines from agencies such as the American Thoracic Society and the European Respiratory Society. More than 100 million spirometry tests are conducted worldwide each year, however the biggest issues are cost and lack of trained personnel.

Spirometer Market Size and Forecast:

• Market Size in 2025: USD 1346.16 Million

• Market Size by 2035: USD 3720.24 Million

• CAGR: 10.70 % from 2026 to 2035

• Base Year: 2025

• Forecast Period: 2026–2035

• Historical Data: 2022–2024

To Get more information On Spirometer Market - Request Free Sample Report

Spirometer Market Trends:

• Rising prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease increasing the demand for spirometry testing in clinical and diagnostic settings

• Growing adoption of portable and handheld spirometers enabling convenient lung function monitoring in hospitals clinics and home healthcare environments

• Increasing integration of digital technologies mobile applications and cloud connectivity to enable real time data analysis and remote patient monitoring

• Rising demand for home based respiratory monitoring devices driven by telehealth expansion and post respiratory infection lung health assessment

• Advancements in spirometry technology including AI assisted interpretation and smart sensors improving diagnostic accuracy and clinical efficiency

U.S. Spirometer Market is valued at USD 317.39 Million in 2025 and is expected to reach USD 1,897 Million by 2035, growing at a CAGR of 8.82% from 2026-2035. 

The U.S. spirometer market is growing due to rising respiratory diseases such as asthma and COPD, increasing adoption of portable spirometers, advancements in digital and AI-enabled diagnostics, expanding geriatric population, and greater emphasis on preventive healthcare and early pulmonary function testing across healthcare settings.

Spirometer Market Drivers

• Adoption of Pulmonary Function Testing in Preventive Care

Spirometry is being used more often in routine health assessments and wellness plans as the need to detect respiratory illnesses becomes more urgent in order to ensure the health and safety of clients. Preventive diagnostics will not only improve patient lives by warning patients of conditions such as asthma and COPD before they worsen and become a chronic problem, but also save downstream health costs. This proactive move has helped keep spirometry as a fixture of respiratory health testing and screening.

Spirometer Market Restraints

• Challenges in Cost, Accessibility, and Skilled Usage

Factors such high cost of advanced spirometer devices restrict their demand in low- and middle-income countries, and market competition between manufacturers are expected to hamper overall growth of the spirometer market during the period of forecast. Healthcare facilities in these regions often lack the capital to invest in sophisticated tools. Moreover, the availability of properly trained people to conduct the tests and interpret results also limits proper use of spirometers, especially in rural and underserved areas. Also, the trouble with general looseness is the agony experienced by these patients all through testing causing untrustworthy outcomes and competition from various deductible devices including top flow meters and imaging advancements. Removing these barriers is key to the market continuing to flourish.

Spirometer Market Opportunities

• Expansion of Home-Based and Remote Respiratory Monitoring

Expanding home healthcare and remote patient monitoring drives the spirometer market growth potential. Mobile apps and cloud-based platforms make it easier for patients to monitor their own lung function from home while enabling healthcare providers to monitor results in real time using a portable and digital spirometer. The increasing usage of telehealth services and the rising prevalence of several chronic respiratory disorders such as asthma, and COPD, which need periodic monitoring, to aid in further boost the trends in the market. The increase in incidence of pollution-induced respiratory disorders and functional respiratory failure primarily due to viral infections is pushing healthcare systems to target preventive care and early disease detection; the rise of consumer-friendly connected spirometry may open up novel growth/usage avenues for spirometry manufacturers and healthcare providers alike.

Spirometer Market Segmentation Analysis:

• By Product: Devices led with 60% share, while Software is the fastest-growing segment.

• By Mechanism: Flow-Sensing Spirometers led with 75% share, while Peak Flow Meters is the fastest-growing segment.

• By Application: COPD led with 50% share, while Asthma is the fastest-growing segment.

Spirometer Market Segment Analysis:

By Product

The market is currently dominated by Devices, which held 60% of the market share in 2023. This segment is growing due to the growing adoption of advanced spirometry devices in healthcare settings and also an increase in home healthcare that is adopting such devices. Handheld and desktop spirometers are important for detecting and managing respiratory diseases such as COPD or asthma. As healthcare increasingly moves toward the home, the market for portable, user-friendly devices is growing, as well.

The Software segment was the fastest-growing, driven by digitalisation of platforms and cloud-based platforms that enable remote monitoring of data analytics. The solutions guide and accompany these spirometers with software applications that allow in-situ diagnosis and/or the remote measurement of certain pathophysiological parameters (telemedicine) which will improve the availability and reliability of respiratory health. Although this segment is being driven by the demand for telemedicine which is projecting in the continuous growth process, still, there are a maximum number of healthcare providers that would be adopting the trend of taking the help of the AI software which would be raising the overall productivity of the diagnosis process.

By Mechanism

Flow-Sensing Spirometers accounted for the majority of spirometers in 2023, holding approximately 75% of the overall spirometer market. This is where their accuracy measurement of airflow rates play an important role in getting to the right diagnosis and treatment of conditions such as COPD and asthma. Advantage of the spirometers These spirometers give reliable and highly accurate results that is best suited for clinical as the well as home healthcare.

In the forecast period, the fastest-growing throughput is expected to be in the Peak Flow Meters segment, mainly due to the growing requirement for affordable, portable diagnostic tools. Peak Flow Meters: Peak flow meters are most widely used for asthma, enabling patients to monitor lung function at home. Increased emphasis on home healthcare and self-management of chronic diseases is anticipated to further contribute to the rapid growth of this segment.

By Application

The COPD application segment was the largest in the market in 2O23, accounting for nearly 5O% of the market. Continuing, COPD continues to be among the leading cause of chronic respiratory diseases worldwide which sudden increases the requirement of spirometers for diagnosis, monitoring, and management of disease. With the increase in the global aging population and increase in pollution, the prevalence of COPD is also increasing, which is expected to propel the demand for spirometry to manage this disease.

Due to increasing number of people suffering from Asthma and the awareness of importance of early diagnosis and regular monitoring of it, Asthma application segment is anticipated to be the fastest growing segment in 2026-2035. With asthma management being a significant public health challenge, particularly in children, tailored testing of pulmonary function, particularly spirometry testing is increasingly called for. Additionally, the increasing attention to home monitoring solutions for asthma has accelerated the development of this segment.

Spirometer Market Regional Analysis:

North America Spirometer Market Insights:

North America dominated the spirometer market and accounted for 42% share owing to the well-established healthcare infrastructure, high adoption of advanced technology, and the extensive investment by government in healthcare. The rise in incidences of respiratory diseases, especially COPD and asthma, as well as a greater adoption of preventive care is supporting the strong demand for spirometry devices in this region. The United States, in particular, plays a pivotal role since spirometers are extensively used in a variety of clinical settings and even for home use.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Live Spirometer Market Insights: 

Besides, the Live Spirometer Market in Europe is also rapidly growing too. Factors such as increased awareness about respiratory diseases and stringent healthcare regulations supporting early diagnosis and continuous monitoring is fueling the growth for the market. For example, there is an increase in demand for spirometry in clinical diagnostics and wellness programs in Germany and the UK. We expect continued growth as solutions that plan to continue building upon such systems become more commonplace throughout healthcare systems.

Asia-Pacific Spirometer Market Insights: 

Asia Pacific is the fastest-growing region for the spirometer market, spurred by rising healthcare investments, worsening pollution levels, and a large patient population affected by respiratory ailments. The demand for affordable diagnostic tools is driving market growth in countries like China, India, and Japan, where chronic respiratory diseases are becoming more common due to rapid urbanization and changing lifestyles. Additionally, ongoing improvements in healthcare infrastructure are expected to drive further market expansion in the region.

Latin America Spirometer Market Insights: 

The regional extension of the Latin America spirometer market is expected to expand steadily as the incidence of chronic illnesses such as diabetes rises and as customer demand for comfortable drug administration systems grows. Countries including Brazil, Mexico and Argentina are witnessing increased adoption of spirometer as a act of improved healthcare accessibility and the rising awareness on self-administered therapies. Market Trends In addition, government programs to increase diabetes accessibility and healthcare infrastructure will further contribute to market growth. Moreover, the growing patient population along with increasing inclination towards advanced medical devices are estimated to provide lucrative growth opportunities in the region.

Middle East & Africa (MEA) Spirometer Market Insights: 

The Middle East & Africa Spirometer market is gradually expanding, supported by the increasing burden of diabetes and other chronic conditions requiring injectable therapies. Rising healthcare investments and improving access to modern medical technologies in countries such as the UAE, Saudi Arabia, and South Africa are encouraging the adoption of Spirometers. Moreover, growing awareness about self-injection devices and the expansion of private healthcare facilities are contributing to market growth. However, limited healthcare access in certain regions and affordability challenges may slightly restrain the overall market expansion.

Spirometer Market Competitive Landscape: 

Theravance Biopharma, Inc.

Theravance Biopharma, Inc. is a biopharmaceutical company focused on discovering and commercializing new medicines for patients with respiratory disease and other serious conditions. Tuesday's acquisition was announced by the North Carolina-based company, known for its efforts in developing treatments for chronic obstructive pulmonary disease (COPD) -- including YUPELRI (revefenacin), its nebulized long-acting muscarinic antagonist therapy. Theravance partners globally to deliver highly effective solutions to patients and improve the lives of patients in the area of respiratory care to treat patients with chronic lung diseases.

• October 2024, Theravance published an area-under-the-curve spirometry analysis of YUPELRI (revefenacin) in the International Journal of Chronic Obstructive Pulmonary Disease. The study highlighted improved lung function performance and provided deeper clinical insights into the drug’s effectiveness for COPD management, supporting its role in advanced respiratory treatment strategies.

NuvoAir AB

NuvoAir AB– a digital health firm with connected respiratory diagnostics and remote patient monitoring solutions. The devices include portable spirometry insights in conjunction with digital platforms capable of guiding healthcare providers to monitor and manage patients with chronic respiratory and cardiopulmonary diseases in an out-of-hospital setting. With an emphasis on the long-term care of diseases, NuvoAir hopes to incorporate spirometry telehealth systems with other devices for improved remote integration.

• January 2024, NuvoAir Medical received U.S. FDA 510(k) clearance for its Air Next Spirometer, allowing the device to be used as a full spirometer for in-home applications. The approval enables NuvoAir to expand its clinical programs and strengthen remote respiratory monitoring for patients with heart and lung conditions.

Alveofit (Roundworks Technologies Private Limited)

Alveofit is a comprehensive solution developed by Roundworks Technologies Private Limited, a health technology company committed to digital respiratory care and lung function monitoring solutions. As such, the firm develops spirometers that can be linked with a smartphone, intending to make respiratory diagnostics more accessible and cheap. It offers products that enable remote monitoring and early diagnosis of respiratory diseases (i.e., asthma and COPD) with a focus on emerging markets.

• September 2023, Alveofit received U.S. FDA clearance for its alveoair spirometer, marking a major milestone for the company’s global expansion. The approval strengthens its efforts to provide affordable digital respiratory care and supports strategic collaborations, including partnerships with pharmaceutical companies such as AstraZeneca to expand access in international markets.

Spirometer  Market Key Players: 

• Schiller

• Smiths Medical

• Vyaire Medical

• SDI Diagnostics

• nSpire Health Inc.

• Fukuda Sangyo Co. Ltd.

• Sibelmed

• Vitalograph

• Geratherm Respiratory AG

• Koninklijke Philips N.V.

• Welch Allyn (Hill-Rom, Inc.)

• Midmark Corp.

• Futuremed

• COSMED

• MGC Diagnostics Corporation

• Medical International Research (MIR)

• ndd Medical Technologies

• Jones Medical Instrument Company

• Medline

• Teleflex